2008
DOI: 10.1016/j.ab.2007.09.005
|View full text |Cite
|
Sign up to set email alerts
|

Apolipoprotein E isoform-specific binding to the low-density lipoprotein receptor

Abstract: Apolipoprotein E (apoE) is a ligand for members of the low-density lipoprotein receptor (LDLR) family and functions in plasma cholesterol homeostasis. A fluorescence-based assay has been employed in molecular studies of receptor-ligand interactions. Competition experiments revealed isoform specific differences in binding of lipid-associated apoE N terminal (NT) domain to a recombinant soluble LDLR (sLDLR). In a similar manner, lipid associated, but not lipid-free, fulllength apoE3 showed binding activity to sL… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
32
0
2

Year Published

2009
2009
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 52 publications
(35 citation statements)
references
References 23 publications
1
32
0
2
Order By: Relevance
“…This finding is, however, in accordance with several other studies of untreated patients with FH [31,[39][40][41]. The higher LDL-C levels seen in normal populations carrying an APOE4 is not completely understood, but it may result in part from the higher affinity of APOE4 for the LDLR [42,43]. This higher affinity is believed to promote an increased hepatic uptake of VLDL and IDL remnants, resulting in a downregulation of LDLR activity and, consequently, increased LDL-C levels [44,45].…”
Section: Discussionsupporting
confidence: 92%
“…This finding is, however, in accordance with several other studies of untreated patients with FH [31,[39][40][41]. The higher LDL-C levels seen in normal populations carrying an APOE4 is not completely understood, but it may result in part from the higher affinity of APOE4 for the LDLR [42,43]. This higher affinity is believed to promote an increased hepatic uptake of VLDL and IDL remnants, resulting in a downregulation of LDLR activity and, consequently, increased LDL-C levels [44,45].…”
Section: Discussionsupporting
confidence: 92%
“…While numerous lipoprotein receptors have been shown to interact with apoE in the brain, the LDLR is the only receptor in its class of receptors to show varying binding affinities for the three apoE isoforms (E4 > E3 >> E2) (Innerarity et al, 1983, Yamamoto et al, 2008). Interestingly, the increased CVD risk normally associated with APOE4 genotype disappears in Familial Hypercholesterolemia (FH) patients, who lack functioning LDLR (Vermissen et al, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…Based on the structure of apoE3, the arginine side chain projects into the gap between the N-and C-terminal domains. The fact that this residue is at the mouth of the putative lipid-binding site may affect apoE2 binding to lipid and subsequently to the LDL receptor (37)(38)(39), as the gap between the N and C termini may collapse with the smaller cysteine side chain at position 158.…”
Section: Resultsmentioning
confidence: 99%